Measurement of D-dimer as aid in risk evaluation of VTE in elderly patients hospitalized for acute illness: A prospective, multicenter study in China Abstract Purpose: Advanced age and hospitalization are associated with increasing risk of venous thromboembolic (VTE) events. e aim of this study was to investigate whether elevated D-dimer levels could predict VTE events in elderly patients hospitalized for acute illness.
Venous thromboembolism (VTE) is a frequent cause of preventable illness and death in hospitalized patients. Acutely ill patients represent a large population vulnerable to the development of VTE during hospitalization [1] . Hospitalization for acute illness is independently associated with an eight-fold increased risk for VTE [2] and accounts for almost one quarter of all VTE events [3] . e incidence of VTE increases sharply with age [4, 5] and the burden of VTE is expected to grow dramatically as the population ages [6] . Simultaneously, bleeding occurs in the majority of patients with critical illness [7] .
us, there is a need for early and reliable assessment of risk for VTE to enable appropriate triage of a ected patients and to optimize outcome. Assessing the overall risk of VTE in the elderly patient hospitalized for acute medical illness is complicated, as many patients carry more than one risk factor and the e ect of these risk factors tends to be multiplicative rather than additive [8] . In this context, having a marker of coagulation activation would be useful in identifying patients at high risk for VTE who might bene t from pharmacological thromboprophylaxis.
D-dimer levels is the most frequently used biomarker of coagulation and brinolysis activation. Elevated D-dimer can be present in those who are forming and degrading brin at abnormally high rates, even without evidence of a clinically signi cant clot. D-dimer levels have increasingly been studied as markers of coagulation activation in several clinical scenarios [9] [10] [11] . Emerging evidence endorses a 'predictive' role of elevated D-dimer levels for future VTE events in other medical conditions (eg. cancer, prior VTE) [12] [13] [14] . Nevertheless, data on the association between D-dimer levels and VTE events in elderly patients hospitalized for acute medical illness are not yet available. We hypothesized that elevated baseline D-dimer levels could serve as a biomarker for predicting VTE events in this patient population.
Subjects and Methods
e study conformed to the principles of the Declaration of Helsinki. e study protocol was approved by the local Institutional Review Board of each participating site. All subjects provided written informed consent. Data used for analyses came from a multicenter, prospective study designed for investigating the prevalence of VTE in elderly patients hospitalized for acute medical illness. 
Patients
Eligible patients were 60 years of age or older; immobilized (total bed rest with bathroom privileges) for at least three days; had one or more of the following medical conditions at enrollment as documented by a sta physician: acute heart failure, chronic congestive heart failure (New York Heart Association class III or IV), respiratory failure, acute ischemic stroke or acute infectious disease.
Exclusion criteria were as follows: taking anticoagulant or thrombolytic drug at enrollment, recent major surgery (within two months prior to enrollment), evidence of clinically signicant disseminated intravascular coagulation, refusal to give blood sample or participate in the study or if follow-up was deemed to be impossible.
Participants were identi ed consecutively from patients who were eligible in each center. If a patient was admitted to the hospital more than once during the study period, only data of their initial hospitalization was collected.
Baseline information, including birth date, sex, ethnicity, blood pressure, weight, and height, were recorded. Body mass index was calculated by dividing each patient's weight by the height squared (kg/m 2 ).
Information on comorbid diseases and potential VTE risk factors such as prior history of VTE, hypertension, dyslipidemia, chronic atrial brillation, diabetes, cancer and chronic renal failure was obtained during a standardized interview. e diagnosis of hypertension was established either with two blood pressure readings of ≥ 140/90 mmHg or a prior diagnosis of hypertension and current treatment with antihypertensive medications. Similarly, diabetes was diagnosed if the subject had a fasting glucose measurement of > 126 mg/dl, or a random glucose of > 200 mg/dl, or had a prior diagnosis of diabetes and was on treatment with oral hypoglycemic agent(s) or insulin. Dyslipidemia was de ned as total cholesterol > 200 mg/dl, or use of a lipid-lowering medication.
Blood was drawn at enrollment by venipuncture a er an overnight fast. D-dimer plasma concentrations measurement were performed by using the STA Liatest D-dimer assay kit (Diagnostica Stago, Asnieres, France) and elevated D-dimer levels Fan et al. D-dimer and VTE events were de ned as >500 ng/ml. Laboratory technologists performing the D-dimer assays were unaware of patients' clinical presentation or the results of other objective tests.
Endpoints were objectively-veri ed VTE events, de ned as pulmonary embolism (PE) and/or deep venous thrombosis (DVT), within 90 days follow-up. PE was de ned as thrombus at the segmental level detected by multidetector CT angiography or magnetic resonance imaging, or in high-probability cases using planar ventilation/perfusion lung scanning, or at autopsy. Any symptomatic/asymptomatic DVT (proximal or distal) were included in the nal analysis. Patients were screened for asymptomatic DVT by lower limb colour duplex ultrasonography at baseline and 3-week follow-up. e decision to evaluate a patient for other VTE events was le to the discretion of the clinician. Radiologists interpreting these studies were blinded to the patient's D-dimer levels.
e common femoral, deep femoral, femoral, popliteal, posterior tibial, peroneal, gastrocnemious, and soleus veins were scanned in the transverse and longitudinal plane. Duplex criteria for a diagnosis of acute DVT included visualization of thrombus on B-mode, lack of venous compressibility and the absence of Doppler ow signals distal to the site of suspected thrombosis.
All patients were followed up prospectively for 90 days with scheduled visits at three weeks and 90 days a er enrollment. Details of any objectively con rmed VTE episode occurred during follow-up period were recorded. Discharged patients were instructed to return for reevaluation if they developed signs or symptoms suggestive of VTE.
Continuous variables were presented as mean ± standard deviation and categorical data as numbers and percentages (%).
e D-dimer data were reported as the frequency of elevated values and their comparisons were of dichotomized results (elevated vs. normal). Cox proportional hazards analysis was performed to evaluate the independent contribution of elevated D-dimer levels to the risk of VTE event. Initially, hazard ratios and their con dence intervals were estimated in a univariate model. Variable selection in multivariable modeling was based on clinical and statistical signi cance. Signi cant variables from the univariate analysis, together with age, sex, ethnicity, body mass index, D-dimer, and other potential risk factors, were then subjected to multivariate Cox proportional hazard models. Kaplan-Meier survival curves were constructed and strati ed according to D-dimer levels (elevated vs. normal) and comparisons were performed using the log-rank test. All analyses were performed with SAS9.1 (SAS Institute, Cary, N.C., USA) and a two-sided P-value of < 0.05 was deemed statistically signi cant.
Results

Patients
A total of 626 patients were recruited. Data from 168 patients (27%) were excluded (12 because of anticoagulant therapy at enrollment, 96 because of acute coronary syndrome requiring treatment with anticoagulation, 41 because of unwilling to give a blood sample, and 19 because of incomplete data). us, 458 patients were available for analysis. Follow-up was available for all of these patients.
The mean (± standard deviation) age of participants was 77 ± 7years, 65% were men (n = 299), 98% were Han ethnicity (n = 450), and the mean body mass index was 24.8 ± 4.3 kg/ m 2 . Reasons for enrollment were heart failure (n = 247, 54%), respiratory failure (n = 28, 6%), acute ischemic stroke (n = 65, 14%), or acute infectious disease (n = 146, 32%). e prevalence of hypertension and diabetes in this cohort was 38% (n = 176) and 35% (n = 159) , respectively. A total of 61% had experienced coronary heart disease/cerebrovascular disease (n = 281), and 4% had experienced VTE event(s) previously (n = 17). Regarding mechanical thromboprophylaxis, only 0.4% (n = 2) of the patients had used graduated compression stockings and none had used intermittent pneumatic compression.
e main demographic and clinical characteristics of the patients are detailed in Table 1 . e patients were divided into two groups, based on D-dimer levels, and these two groups did not di er in demographic variables. Compared with those who had normal baseline D-dimer levels, patients with elevated baseline D-dimer levels had a higher prevalence of heart failure (59.1% vs. 48.9%; P = 0.029), chronic renal failure (8.9% vs. 3.8%; P = 0.027) and lower prevalence of hypertension (33.8% vs. 42.9%; P = 0.044). In the subgroup of patients with elevated baseline D-dimer levels (Table 2) , the prevalence of heart failure (62.7% vs. 37.5%; P = 0.007) and cardiovascular/ cerebrovascular disease (62.2% vs. 43.7%; P = 0.049) were signi cantly higher in patients without VTE events compared
with those with VTE events. Conversely, the rate of respiratory failure (5.7% vs. 18.7%; P = 0.010) was relatively lower.
Of the total 458 patients, 49.1% (n = 225) had elevated baseline D-dimer levels. During the 90-day follow-up, 45 participants (9.8%) had at least one VTE event, including een (3.3%) asymptomatic/silent DVT cases screened by lower limb colour duplex ultrasonography. ere were 32 (14.2%) cases of VTE in patients with elevated baseline D-dimer levels, as compared with 13 (5.6%) in those with normal levels (Table 1) .
e outcomes of patients with asymptomatic/silent DVT were relatively benign: none developed PE and only 1 (6.7%) died during the 90-day follow-up.
e Kaplan-Meier VTE-free survival curves (Figure 1) show that an elevated D-dimer level was predictive of VTE during the 90-day follow-up (P = 0.002 by the Log-Rank test).
Fan On univariate Cox regression analysis, there was a 2.3-fold increased risk of VTE among patients with elevated D-dimer levels compared with patients with normal D-dimer levels (hazard ratios 2.30; 95% con dence intervals 1.18-4.45; P = 0.014, Table 3 ). In addition, respiratory failure (P = 0.011), infectious disease (P = 0.033) and prior VTE (P = 0.029) were also associated with VTE events. Elevated D-dimer levels was an independent predictor of VTE a er adjustment for demographic factors and body mass index (hazard ratios 2.6; 95% con dence intervals 1.4-5.0; P = 0.004; Table 4 ) and for potential confounding factors including presence of infectious disease, heart failure, respiratory failure, prior VTE, coronary artery disease/cerebrovascular disease, chronic atrial brillation, cancer, chronic obstructive pulmonary disease, chronic renal failure, diabetes, tumor, hypertension and mechanical thromboprophylaxis (hazard ratios 3.2; 95% con dence intervals 1.5-6.5; P = 0.002; Table 4 ).
Discussion
e main nding of this multicenter prospective study was that elevated D-dimer levels at baseline identi ed high risk for VTE in elderly patients hospitalized for acute medical illness. 14.2% of them developed VTE during 90-day follow-up. By contrast, only 5.6% developed VTE in the cohort with normal D-dimer level. ese data indicate that activation of the coagulation system is an important pathophysiologic indicator of occurrence of VTE and the measurement of D-dimer in elderly patients hospitalized for acute medical illness is a valuable tool for identi cation of patients prone to develop VTE.
is is the rst study to demonstrate that elevated Ddimer levels have independent predictive value for the subsequent VTE events in elderly patients hospitalized for acute illness. e patients studied here re ect those usually encountered in clinical practice: they are older than those included in large clinical trials of thromboprophylaxis, in which subjects over 75 years were excluded, and have multiple comorbid con-
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Clin In E100 ditions. Given the fact that this study included only patients without pharmacological thromboprophylaxis and that 0.4% of the study population used mechanical prophylaxis, we believe that results of this study re ect the natural history of the population of this age.
ese results are consistent with previous observations for the role of D-dimer levels in the prediction of initial or recurrent VTE in other patients with other medical conditions [10, 12, [15] [16] [17] . Most importantly, in the present study, the prevalence of VTE in elderly patients hospitalized for acute illness who were also found to have elevated D-dimer levels is 14.2% -much higher than that previously reported in similar patients without consideration of D-dimer levels (3.4 ~ 6.6%) [18] [19] [20] .
e potential value of D-dimer levels as a predictor of VTE in elderly patients hospitalized for acute illness lies in the possibility of pharmacological intervention within a period when the risk of VTE is higher than normal. Selecting patients at highest risk means that antithrombotic prophylaxis can be reserved for those promising the best ratio between likely bene t and risk of e pathophysiological mechanisms leading to the development of VTE and elevated D-dimer levels in elderly patients hospitalized for acute illness remains to be clari ed. D-dimer is formed by the action of plasmin brin clot and generated in the presence of thrombus [21, 22] . D-dimer represents the summation of procoagulant balance, genetic factors or the presence of underlying coagulation disorders that predispose to VTE. Many of the clinical factors in this setting, such as old age, congestive heart failure, respiratory failure, ischemic stroke, infectious disease, in ammatory disorders and bed rest, will a ect the balance of thormobosis and brinolysis activation. e elevated levels of D-dimer may re ect any one of several underlying disease processes that initiate intravascularbrin formation and provide a detectable warning sign of hypercoagulability and increased risk of thrombosis. A normal Ddimer level denotes no major ongoing activation of intravascular coagulation. It must be stressed that the balance of coagulation and brinolysis in the human body changes with disease progression or regression. Repeated D-dimer assays in patients with an originally normal test may be useful in detecting a late hypercoagulability. Much more work needs to be done to determine whether dynamic monitoring of D-dimer levels might provide additional information and might be useful for continuous VTE risk evaluation for elderly patients hospitalized for acute illness.
Interestingly, some typical risk factors for VTE, such as tumor, age and body mass index, were not statistically signicant in the univariate analysis of our study (Table 3 ). e likely explanation is only elderly patients (mean age 77 yrs) were enrolled in the study and that the prevalence of patients with cancer (n = 29, 6.3%) or obesity (mean BMI 24.8 ± 4.3 kg/m 2 ) was relatively low in this study. us, it is di cult to draw conclusion on the relationship among these factors and VTE.
Our study had several methodological strengths. e main strength is its prospective design with screening of consecutive eligible patients and use of a standardized data collection. Data were rarely missing. Another strength was that diagnosis and management of patients was determined by the treating physicians, and hence the data re ect a real-world approach to these patients; patients included both sexes and represented a broad spectrum of clinical characteristics. Moreover, we included asymptomatic DVT cases con rmed by colour duplex ultrasonography without exposing our fragile patients to an invasive procedure.
Even so, however, a few points should be considered in interpreting these ndings. First, this study focused especially on elderly inpatients hospitalized for acute illness without pharmacological thromboprophylaxis, the applicability of our ndings to other patients requires further study. Second, it is possible that our data on comorbidity or other clinical factors were insu cient to allow us to fully adjust for potentially confounded e ects. Finally, only clinically identi ed VTE events were included. While all patients were followed for 90 days, silent or non-clinically evident VTE complications could have occurred.
Conclusions
Our study shows that elevated baseline D-dimer levels are associated with subsequent VTE events in elderly patients hospitalized for acute medical illness. e strength of the association observed here suggests that the measurement of D-dimer levels in plasma has a de nite place in the procedure for identifying high-risk VTE patients.
